BMY-27709 is an influenza virus growth inhibitor with an IC50 value of 3–8 μM against A/WSN/33 virus; it exhibits inhibitory activity against certain influenza virus subtypes, particularly H1 and H2, by inhibiting hemagglutinin protein during the early stages of infection; however, it shows no activity against H3 subtype or influenza B/Lee/40 virus.